AS Tere

Tere AS is a leading Estonian dairy company that has integrated advanced biotechnology into its product portfolio through a 20-year partnership with the University of Tartu. The company is the primary commercializer of the patented Lactobacillus fermentum ME-3 probiotic strain, marketed under the "Hellus" brand, which is clinically validated for its antioxidant and cholesterol-lowering effects. This focus on functional foods positions Tere at the intersection of nutrition and preventive healthcare, with products designed to manage metabolic syndrome and cardiovascular health. Following its 2017 acquisition by Maag Grupp, Tere continues to expand its health-oriented offerings across the Baltic region and international markets.